MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Akoya Biosciences Inc. (AKYA) on Thursday reported a loss of $10.5 million in its third quarter.
On a per-share basis, the Marlborough, Massachusetts-based company said it had a loss of 21 cents. Losses, adjusted for restructuring costs, were 18 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
The tissue analysis provider posted revenue of $18.8 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $25.2 million.
Akoya expects full-year revenue in the range of $80 million to $85 million.
In the final minutes of trading on Thursday, the company's shares hit $3.12. A year ago, they were trading at $4.42.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKYA at https://www.zacks.com/ap/AKYA
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
No relevant data is available